ISIN | CH0008389634 |
---|---|
Valor Number | 838963 |
Bloomberg Global ID | |
Fund Name | Win Fund Equity-Index Switzerland A |
Fund Provider |
UBS Fund Management (Switzerland) AG
Basel, Switzerland Phone: +41 61 288 75 01 E-Mail: sh-ubs-funds-feedback@ubs.com Web: www.ubs.com/fonds |
Fund Provider | UBS Fund Management (Switzerland) AG |
Representative in Switzerland |
UBS Fund Management (Switzerland) AG Basel Phone: +41 61 288 49 10 |
Distributor(s) |
AXA Winterthur Winterthur Phone: +41 52 261 11 11 UBS AG Basel Phone: +41 61 288 75 01 |
Asset Class | Equities |
EFC Category | |
Distribution Policy | Distribution |
Home Country | Switzerland |
Issuing Condition | Combination of issuing commission charged by the fund management company and transaction fee charged by the fund |
Redemption Condition | The fund charges a transaction fee (contribution towards covering expenses incurred in the sale of assets) |
Investment Strategy *** | The fund is invested in equities of companies in Switzerland. The fund is suitable for investors seeking to participate in the development of the Swiss equity market and willing to accept a moderate risk. |
Peculiarities |
Current Price * | 210.40 CHF | 31.10.2024 |
---|---|---|
Previous Price * | 213.53 CHF | 30.10.2024 |
52 Week High * | 222.27 CHF | 02.09.2024 |
52 Week Low * | 187.68 CHF | 10.11.2023 |
NAV * | 210.40 CHF | 31.10.2024 |
Issue Price * | ||
Redemption Price * | ||
Closing Price * | ||
Indicative Minimum Price | ||
Fund Assets *** | 24,557,188 | |
Unit/Share Assets *** | 24,557,188 | |
Trading Information SIX |
YTD Performance | +6.40% |
29.12.2023 - 31.10.2024
29.12.2023 31.10.2024 |
---|---|---|
1 month | -3.19% |
30.09.2024 - 31.10.2024
30.09.2024 31.10.2024 |
3 months | -4.41% |
31.07.2024 - 31.10.2024
31.07.2024 31.10.2024 |
6 months | +4.66% |
30.04.2024 - 31.10.2024
30.04.2024 31.10.2024 |
1 year | +13.85% |
31.10.2023 - 31.10.2024
31.10.2023 31.10.2024 |
2 years | +9.72% |
31.10.2022 - 31.10.2024
31.10.2022 31.10.2024 |
3 years | -2.30% |
01.11.2021 - 31.10.2024
01.11.2021 31.10.2024 |
5 years | +18.24% |
31.10.2019 - 31.10.2024
31.10.2019 31.10.2024 |
Equity Participation Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Share of Total Fund Assets in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Real Estate Rate in % | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
ADDI Date |
Nestle SA | 16.35% | |
---|---|---|
Novartis AG Registered Shares | 15.76% | |
Roche Holding AG | 15.23% | |
UBS Group AG | 6.34% | |
ABB Ltd | 5.86% | |
Compagnie Financiere Richemont SA Class A | 5.43% | |
Zurich Insurance Group AG | 5.43% | |
Holcim Ltd | 3.34% | |
Sika AG | 3.30% | |
Lonza Group Ltd | 3.12% | |
Last data update | 31.08.2024 |
TER | 1.09% |
---|---|
TER date | 31.12.2023 |
Performance Fee *** | |
PTR | |
Max. Management Fee *** | 1.00% |
Ongoing Charges *** | 1.08% |
SRRI ***
|
|
SRRI date *** | 30.09.2024 |
Low Carbon Designation *** | |
---|---|
ESG Rating Overall *** | |
ESG Rating Corporate *** | |
ESG Rating Sovereign *** | |
% AuM H&S Controversies *** |
Avg Carbon Risk Score *** | |
---|---|
Avg Carbon Risk Cat Avg *** | |
% AuM Covered Carbon *** | |
Avg Fossil Fuel Exposure *** | |
Fossil Fuel Cat Avg *** |
Strategy Level 1 *** | |
---|---|
Strategy Level 2 *** | |
Strategy Level 3 *** | |
Exclusions Level 1 *** | |
Exclusions Level 2 *** |